This study demonstrates that low DARPP-32 protein expression is associated with shorter survival in two large, independent, early stage invasive breast cancer patient cohorts, with a stronger association observed in ER positive disease. This evidence concerns the gene PPP1R1B and invasive breast carcinoma.